nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00151	0.00169	CcSEcCtD
Dimenhydrinate—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00169	CcSEcCtD
Dimenhydrinate—Convulsion—Gliclazide—type 2 diabetes mellitus	0.0015	0.00168	CcSEcCtD
Dimenhydrinate—Anorexia—Glyburide—type 2 diabetes mellitus	0.0015	0.00168	CcSEcCtD
Dimenhydrinate—Vision blurred—Valsartan—type 2 diabetes mellitus	0.0015	0.00168	CcSEcCtD
Dimenhydrinate—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00149	0.00167	CcSEcCtD
Dimenhydrinate—Chills—Metformin—type 2 diabetes mellitus	0.00149	0.00167	CcSEcCtD
Dimenhydrinate—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00166	CcSEcCtD
Dimenhydrinate—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00148	0.00166	CcSEcCtD
Dimenhydrinate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00147	0.00165	CcSEcCtD
Dimenhydrinate—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00165	CcSEcCtD
Dimenhydrinate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00147	0.00165	CcSEcCtD
Dimenhydrinate—Hypotension—Glyburide—type 2 diabetes mellitus	0.00147	0.00164	CcSEcCtD
Dimenhydrinate—Nausea—Repaglinide—type 2 diabetes mellitus	0.00147	0.00164	CcSEcCtD
Dimenhydrinate—Asthenia—Glipizide—type 2 diabetes mellitus	0.00147	0.00164	CcSEcCtD
Dimenhydrinate—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.00146	0.00164	CcSEcCtD
Dimenhydrinate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00146	0.00164	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.00144	0.00162	CcSEcCtD
Dimenhydrinate—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00144	0.00161	CcSEcCtD
Dimenhydrinate—Vertigo—Valsartan—type 2 diabetes mellitus	0.00143	0.0016	CcSEcCtD
Dimenhydrinate—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00142	0.00159	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00159	CcSEcCtD
Dimenhydrinate—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00141	0.00158	CcSEcCtD
Dimenhydrinate—Vertigo—Orlistat—type 2 diabetes mellitus	0.00141	0.00158	CcSEcCtD
Dimenhydrinate—Chills—Irbesartan—type 2 diabetes mellitus	0.00141	0.00158	CcSEcCtD
Dimenhydrinate—Palpitations—Valsartan—type 2 diabetes mellitus	0.0014	0.00157	CcSEcCtD
Dimenhydrinate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.0014	0.00157	CcSEcCtD
Dimenhydrinate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.0014	0.00156	CcSEcCtD
Dimenhydrinate—Palpitations—Orlistat—type 2 diabetes mellitus	0.00139	0.00155	CcSEcCtD
Dimenhydrinate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00139	0.00155	CcSEcCtD
Dimenhydrinate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00138	0.00155	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00138	0.00155	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00138	0.00155	CcSEcCtD
Dimenhydrinate—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00138	0.00154	CcSEcCtD
Dimenhydrinate—Tinnitus—Losartan—type 2 diabetes mellitus	0.00138	0.00154	CcSEcCtD
Dimenhydrinate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00137	0.00153	CcSEcCtD
Dimenhydrinate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00137	0.00153	CcSEcCtD
Dimenhydrinate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00153	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00136	0.00153	CcSEcCtD
Dimenhydrinate—Vision blurred—Metformin—type 2 diabetes mellitus	0.00136	0.00153	CcSEcCtD
Dimenhydrinate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00136	0.00153	CcSEcCtD
Dimenhydrinate—Convulsion—Orlistat—type 2 diabetes mellitus	0.00136	0.00152	CcSEcCtD
Dimenhydrinate—Tremor—Metformin—type 2 diabetes mellitus	0.00136	0.00152	CcSEcCtD
Dimenhydrinate—Dizziness—Glipizide—type 2 diabetes mellitus	0.00135	0.00151	CcSEcCtD
Dimenhydrinate—Tension—Irbesartan—type 2 diabetes mellitus	0.00134	0.0015	CcSEcCtD
Dimenhydrinate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00134	0.0015	CcSEcCtD
Dimenhydrinate—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00133	0.00148	CcSEcCtD
Dimenhydrinate—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00132	0.00148	CcSEcCtD
Dimenhydrinate—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00132	0.00148	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00132	0.00147	CcSEcCtD
Dimenhydrinate—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00131	0.00146	CcSEcCtD
Dimenhydrinate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.0013	0.00146	CcSEcCtD
Dimenhydrinate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0013	0.00146	CcSEcCtD
Dimenhydrinate—Vomiting—Glipizide—type 2 diabetes mellitus	0.0013	0.00145	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.0013	0.00145	CcSEcCtD
Dimenhydrinate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00129	0.00145	CcSEcCtD
Dimenhydrinate—Rash—Glipizide—type 2 diabetes mellitus	0.00129	0.00144	CcSEcCtD
Dimenhydrinate—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00129	0.00144	CcSEcCtD
Dimenhydrinate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00129	0.00144	CcSEcCtD
Dimenhydrinate—Headache—Glipizide—type 2 diabetes mellitus	0.00128	0.00143	CcSEcCtD
Dimenhydrinate—Tremor—Irbesartan—type 2 diabetes mellitus	0.00128	0.00143	CcSEcCtD
Dimenhydrinate—Palpitations—Metformin—type 2 diabetes mellitus	0.00128	0.00143	CcSEcCtD
Dimenhydrinate—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00128	0.00143	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00127	0.00142	CcSEcCtD
Dimenhydrinate—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00127	0.00142	CcSEcCtD
Dimenhydrinate—Tension—Losartan—type 2 diabetes mellitus	0.00126	0.00141	CcSEcCtD
Dimenhydrinate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00126	0.00141	CcSEcCtD
Dimenhydrinate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00126	0.00141	CcSEcCtD
Dimenhydrinate—Agitation—Irbesartan—type 2 diabetes mellitus	0.00125	0.00141	CcSEcCtD
Dimenhydrinate—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00125	0.0014	CcSEcCtD
Dimenhydrinate—Urticaria—Glyburide—type 2 diabetes mellitus	0.00125	0.0014	CcSEcCtD
Dimenhydrinate—Nervousness—Losartan—type 2 diabetes mellitus	0.00125	0.0014	CcSEcCtD
Dimenhydrinate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00124	0.00139	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00124	0.00139	CcSEcCtD
Dimenhydrinate—Anorexia—Valsartan—type 2 diabetes mellitus	0.00124	0.00138	CcSEcCtD
Dimenhydrinate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00123	0.00138	CcSEcCtD
Dimenhydrinate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00123	0.00137	CcSEcCtD
Dimenhydrinate—Headache—Pioglitazone—type 2 diabetes mellitus	0.00123	0.00137	CcSEcCtD
Dimenhydrinate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00122	0.00136	CcSEcCtD
Dimenhydrinate—Nausea—Glipizide—type 2 diabetes mellitus	0.00121	0.00136	CcSEcCtD
Dimenhydrinate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00121	0.00136	CcSEcCtD
Dimenhydrinate—Hypotension—Valsartan—type 2 diabetes mellitus	0.00121	0.00136	CcSEcCtD
Dimenhydrinate—Vision blurred—Losartan—type 2 diabetes mellitus	0.00121	0.00136	CcSEcCtD
Dimenhydrinate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00121	0.00135	CcSEcCtD
Dimenhydrinate—Constipation—Gliclazide—type 2 diabetes mellitus	0.00121	0.00135	CcSEcCtD
Dimenhydrinate—Tremor—Losartan—type 2 diabetes mellitus	0.0012	0.00135	CcSEcCtD
Dimenhydrinate—Rash—Glimepiride—type 2 diabetes mellitus	0.0012	0.00135	CcSEcCtD
Dimenhydrinate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.0012	0.00134	CcSEcCtD
Dimenhydrinate—Rash—Sitagliptin—type 2 diabetes mellitus	0.0012	0.00134	CcSEcCtD
Dimenhydrinate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0012	0.00134	CcSEcCtD
Dimenhydrinate—Headache—Glimepiride—type 2 diabetes mellitus	0.00119	0.00134	CcSEcCtD
Dimenhydrinate—Headache—Sitagliptin—type 2 diabetes mellitus	0.00119	0.00133	CcSEcCtD
Dimenhydrinate—Agitation—Losartan—type 2 diabetes mellitus	0.00118	0.00132	CcSEcCtD
Dimenhydrinate—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00118	0.00132	CcSEcCtD
Dimenhydrinate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00132	CcSEcCtD
Dimenhydrinate—Insomnia—Valsartan—type 2 diabetes mellitus	0.00117	0.00131	CcSEcCtD
Dimenhydrinate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00116	0.0013	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00116	0.0013	CcSEcCtD
Dimenhydrinate—Insomnia—Orlistat—type 2 diabetes mellitus	0.00116	0.0013	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00116	0.00129	CcSEcCtD
Dimenhydrinate—Vertigo—Losartan—type 2 diabetes mellitus	0.00115	0.00129	CcSEcCtD
Dimenhydrinate—Somnolence—Valsartan—type 2 diabetes mellitus	0.00115	0.00129	CcSEcCtD
Dimenhydrinate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00115	0.00129	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00114	0.00128	CcSEcCtD
Dimenhydrinate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00114	0.00128	CcSEcCtD
Dimenhydrinate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00114	0.00127	CcSEcCtD
Dimenhydrinate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00114	0.00127	CcSEcCtD
Dimenhydrinate—Palpitations—Losartan—type 2 diabetes mellitus	0.00114	0.00127	CcSEcCtD
Dimenhydrinate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00113	0.00127	CcSEcCtD
Dimenhydrinate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00113	0.00126	CcSEcCtD
Dimenhydrinate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00113	0.00126	CcSEcCtD
Dimenhydrinate—Asthenia—Glyburide—type 2 diabetes mellitus	0.00113	0.00126	CcSEcCtD
Dimenhydrinate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00113	0.00126	CcSEcCtD
Dimenhydrinate—Anorexia—Metformin—type 2 diabetes mellitus	0.00113	0.00126	CcSEcCtD
Dimenhydrinate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00112	0.00126	CcSEcCtD
Dimenhydrinate—Fatigue—Valsartan—type 2 diabetes mellitus	0.00112	0.00125	CcSEcCtD
Dimenhydrinate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00111	0.00125	CcSEcCtD
Dimenhydrinate—Constipation—Valsartan—type 2 diabetes mellitus	0.00111	0.00124	CcSEcCtD
Dimenhydrinate—Fatigue—Orlistat—type 2 diabetes mellitus	0.0011	0.00124	CcSEcCtD
Dimenhydrinate—Hypotension—Metformin—type 2 diabetes mellitus	0.0011	0.00124	CcSEcCtD
Dimenhydrinate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00122	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00109	0.00122	CcSEcCtD
Dimenhydrinate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00109	0.00122	CcSEcCtD
Dimenhydrinate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00108	0.00121	CcSEcCtD
Dimenhydrinate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00108	0.00121	CcSEcCtD
Dimenhydrinate—Tension—Ramipril—type 2 diabetes mellitus	0.00108	0.00121	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00108	0.00121	CcSEcCtD
Dimenhydrinate—Headache—Bromocriptine—type 2 diabetes mellitus	0.00108	0.00121	CcSEcCtD
Dimenhydrinate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00108	0.0012	CcSEcCtD
Dimenhydrinate—Nervousness—Ramipril—type 2 diabetes mellitus	0.00107	0.0012	CcSEcCtD
Dimenhydrinate—Dry mouth—Losartan—type 2 diabetes mellitus	0.00107	0.0012	CcSEcCtD
Dimenhydrinate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00106	0.00119	CcSEcCtD
Dimenhydrinate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00106	0.00119	CcSEcCtD
Dimenhydrinate—Confusional state—Losartan—type 2 diabetes mellitus	0.00106	0.00118	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00106	0.00118	CcSEcCtD
Dimenhydrinate—Somnolence—Metformin—type 2 diabetes mellitus	0.00105	0.00118	CcSEcCtD
Dimenhydrinate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00104	0.00117	CcSEcCtD
Dimenhydrinate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00104	0.00116	CcSEcCtD
Dimenhydrinate—Tremor—Ramipril—type 2 diabetes mellitus	0.00103	0.00116	CcSEcCtD
Dimenhydrinate—Urticaria—Valsartan—type 2 diabetes mellitus	0.00103	0.00115	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00103	0.00115	CcSEcCtD
Dimenhydrinate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00103	0.00115	CcSEcCtD
Dimenhydrinate—Tachycardia—Losartan—type 2 diabetes mellitus	0.00102	0.00115	CcSEcCtD
Dimenhydrinate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00114	CcSEcCtD
Dimenhydrinate—Fatigue—Metformin—type 2 diabetes mellitus	0.00102	0.00114	CcSEcCtD
Dimenhydrinate—Urticaria—Orlistat—type 2 diabetes mellitus	0.00102	0.00114	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00101	0.00114	CcSEcCtD
Dimenhydrinate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00101	0.00113	CcSEcCtD
Dimenhydrinate—Agitation—Ramipril—type 2 diabetes mellitus	0.00101	0.00113	CcSEcCtD
Dimenhydrinate—Constipation—Metformin—type 2 diabetes mellitus	0.00101	0.00113	CcSEcCtD
Dimenhydrinate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.001	0.00112	CcSEcCtD
Dimenhydrinate—Anorexia—Losartan—type 2 diabetes mellitus	0.001	0.00112	CcSEcCtD
Dimenhydrinate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000999	0.00112	CcSEcCtD
Dimenhydrinate—Rash—Glyburide—type 2 diabetes mellitus	0.000991	0.00111	CcSEcCtD
Dimenhydrinate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000991	0.00111	CcSEcCtD
Dimenhydrinate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00099	0.00111	CcSEcCtD
Dimenhydrinate—Vertigo—Ramipril—type 2 diabetes mellitus	0.00099	0.00111	CcSEcCtD
Dimenhydrinate—Headache—Glyburide—type 2 diabetes mellitus	0.000985	0.0011	CcSEcCtD
Dimenhydrinate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000981	0.0011	CcSEcCtD
Dimenhydrinate—Hypotension—Losartan—type 2 diabetes mellitus	0.00098	0.0011	CcSEcCtD
Dimenhydrinate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000974	0.00109	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000973	0.00109	CcSEcCtD
Dimenhydrinate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000969	0.00108	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000966	0.00108	CcSEcCtD
Dimenhydrinate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000961	0.00108	CcSEcCtD
Dimenhydrinate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000955	0.00107	CcSEcCtD
Dimenhydrinate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000953	0.00107	CcSEcCtD
Dimenhydrinate—Insomnia—Losartan—type 2 diabetes mellitus	0.000948	0.00106	CcSEcCtD
Dimenhydrinate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000942	0.00105	CcSEcCtD
Dimenhydrinate—Urticaria—Metformin—type 2 diabetes mellitus	0.000938	0.00105	CcSEcCtD
Dimenhydrinate—Nausea—Glyburide—type 2 diabetes mellitus	0.000934	0.00105	CcSEcCtD
Dimenhydrinate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000933	0.00105	CcSEcCtD
Dimenhydrinate—Somnolence—Losartan—type 2 diabetes mellitus	0.000932	0.00104	CcSEcCtD
Dimenhydrinate—Asthenia—Valsartan—type 2 diabetes mellitus	0.00093	0.00104	CcSEcCtD
Dimenhydrinate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000923	0.00103	CcSEcCtD
Dimenhydrinate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000919	0.00103	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000918	0.00103	CcSEcCtD
Dimenhydrinate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000917	0.00103	CcSEcCtD
Dimenhydrinate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000912	0.00102	CcSEcCtD
Dimenhydrinate—Confusional state—Ramipril—type 2 diabetes mellitus	0.000907	0.00102	CcSEcCtD
Dimenhydrinate—Fatigue—Losartan—type 2 diabetes mellitus	0.000904	0.00101	CcSEcCtD
Dimenhydrinate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000897	0.001	CcSEcCtD
Dimenhydrinate—Constipation—Losartan—type 2 diabetes mellitus	0.000897	0.001	CcSEcCtD
Dimenhydrinate—Rash—Gliclazide—type 2 diabetes mellitus	0.00089	0.000996	CcSEcCtD
Dimenhydrinate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000889	0.000996	CcSEcCtD
Dimenhydrinate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000887	0.000993	CcSEcCtD
Dimenhydrinate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000885	0.000991	CcSEcCtD
Dimenhydrinate—Headache—Gliclazide—type 2 diabetes mellitus	0.000884	0.00099	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00088	0.000986	CcSEcCtD
Dimenhydrinate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000878	0.000983	CcSEcCtD
Dimenhydrinate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000877	0.000982	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000869	0.000973	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000864	0.000968	CcSEcCtD
Dimenhydrinate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000857	0.00096	CcSEcCtD
Dimenhydrinate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000857	0.00096	CcSEcCtD
Dimenhydrinate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000847	0.000949	CcSEcCtD
Dimenhydrinate—Asthenia—Metformin—type 2 diabetes mellitus	0.000847	0.000949	CcSEcCtD
Dimenhydrinate—Hypotension—Ramipril—type 2 diabetes mellitus	0.00084	0.000941	CcSEcCtD
Dimenhydrinate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000838	0.000939	CcSEcCtD
Dimenhydrinate—Urticaria—Losartan—type 2 diabetes mellitus	0.000833	0.000933	CcSEcCtD
Dimenhydrinate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000824	0.000923	CcSEcCtD
Dimenhydrinate—Rash—Valsartan—type 2 diabetes mellitus	0.000818	0.000915	CcSEcCtD
Dimenhydrinate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000817	0.000915	CcSEcCtD
Dimenhydrinate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000815	0.000912	CcSEcCtD
Dimenhydrinate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000813	0.000911	CcSEcCtD
Dimenhydrinate—Headache—Valsartan—type 2 diabetes mellitus	0.000812	0.00091	CcSEcCtD
Dimenhydrinate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000808	0.000905	CcSEcCtD
Dimenhydrinate—Rash—Orlistat—type 2 diabetes mellitus	0.000808	0.000905	CcSEcCtD
Dimenhydrinate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000807	0.000904	CcSEcCtD
Dimenhydrinate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000807	0.000904	CcSEcCtD
Dimenhydrinate—Headache—Orlistat—type 2 diabetes mellitus	0.000803	0.000899	CcSEcCtD
Dimenhydrinate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000799	0.000895	CcSEcCtD
Dimenhydrinate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000799	0.000895	CcSEcCtD
Dimenhydrinate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000791	0.000886	CcSEcCtD
Dimenhydrinate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000782	0.000875	CcSEcCtD
Dimenhydrinate—Dizziness—Metformin—type 2 diabetes mellitus	0.000781	0.000874	CcSEcCtD
Dimenhydrinate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000775	0.000868	CcSEcCtD
Dimenhydrinate—Nausea—Valsartan—type 2 diabetes mellitus	0.00077	0.000862	CcSEcCtD
Dimenhydrinate—Constipation—Ramipril—type 2 diabetes mellitus	0.000769	0.000861	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000762	0.000854	CcSEcCtD
Dimenhydrinate—Nausea—Orlistat—type 2 diabetes mellitus	0.000761	0.000852	CcSEcCtD
Dimenhydrinate—Asthenia—Losartan—type 2 diabetes mellitus	0.000752	0.000843	CcSEcCtD
Dimenhydrinate—Vomiting—Metformin—type 2 diabetes mellitus	0.000751	0.000841	CcSEcCtD
Dimenhydrinate—Rash—Metformin—type 2 diabetes mellitus	0.000744	0.000834	CcSEcCtD
Dimenhydrinate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000744	0.000833	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000741	0.00083	CcSEcCtD
Dimenhydrinate—Headache—Metformin—type 2 diabetes mellitus	0.00074	0.000828	CcSEcCtD
Dimenhydrinate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000737	0.000825	CcSEcCtD
Dimenhydrinate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000717	0.000803	CcSEcCtD
Dimenhydrinate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000714	0.0008	CcSEcCtD
Dimenhydrinate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000708	0.000793	CcSEcCtD
Dimenhydrinate—Rash—Irbesartan—type 2 diabetes mellitus	0.000703	0.000787	CcSEcCtD
Dimenhydrinate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000702	0.000786	CcSEcCtD
Dimenhydrinate—Nausea—Metformin—type 2 diabetes mellitus	0.000701	0.000785	CcSEcCtD
Dimenhydrinate—Headache—Irbesartan—type 2 diabetes mellitus	0.000698	0.000782	CcSEcCtD
Dimenhydrinate—Dizziness—Losartan—type 2 diabetes mellitus	0.000693	0.000777	CcSEcCtD
Dimenhydrinate—Vomiting—Losartan—type 2 diabetes mellitus	0.000667	0.000747	CcSEcCtD
Dimenhydrinate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000662	0.000741	CcSEcCtD
Dimenhydrinate—Rash—Losartan—type 2 diabetes mellitus	0.000661	0.00074	CcSEcCtD
Dimenhydrinate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000661	0.00074	CcSEcCtD
Dimenhydrinate—Headache—Losartan—type 2 diabetes mellitus	0.000657	0.000736	CcSEcCtD
Dimenhydrinate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000645	0.000722	CcSEcCtD
Dimenhydrinate—Nausea—Losartan—type 2 diabetes mellitus	0.000623	0.000698	CcSEcCtD
Dimenhydrinate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000615	0.000689	CcSEcCtD
Dimenhydrinate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000595	0.000666	CcSEcCtD
Dimenhydrinate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000572	0.00064	CcSEcCtD
Dimenhydrinate—Rash—Ramipril—type 2 diabetes mellitus	0.000567	0.000635	CcSEcCtD
Dimenhydrinate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000566	0.000634	CcSEcCtD
Dimenhydrinate—Headache—Ramipril—type 2 diabetes mellitus	0.000563	0.000631	CcSEcCtD
Dimenhydrinate—Nausea—Ramipril—type 2 diabetes mellitus	0.000534	0.000598	CcSEcCtD
Dimenhydrinate—Modafinil—CYP1A2—type 2 diabetes mellitus	0.000502	0.287	CrCbGaD
Dimenhydrinate—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000349	0.2	CrCbGaD
Dimenhydrinate—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000347	0.198	CrCbGaD
Dimenhydrinate—Modafinil—CYP3A4—type 2 diabetes mellitus	0.000332	0.19	CrCbGaD
Dimenhydrinate—Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.000218	0.125	CrCbGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000114	0.00109	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000113	0.00107	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000113	0.00107	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000112	0.00106	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000112	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000111	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000111	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.00011	0.00105	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.00011	0.00105	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000109	0.00104	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000109	0.00103	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000108	0.00102	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000107	0.00102	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000107	0.00101	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000106	0.00101	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000106	0.001	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000105	0.000998	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000104	0.000992	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000104	0.000988	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000104	0.000983	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000103	0.000983	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000103	0.000978	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000102	0.000967	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000102	0.000967	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000102	0.000967	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000102	0.000966	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000101	0.000963	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.0001	0.000951	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.0001	0.00095	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	9.96e-05	0.000946	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.87e-05	0.000937	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GIP—type 2 diabetes mellitus	9.8e-05	0.000931	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.71e-05	0.000922	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.6e-05	0.000912	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.47e-05	0.000899	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	9.45e-05	0.000897	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.45e-05	0.000897	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.42e-05	0.000895	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.39e-05	0.000892	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.36e-05	0.000889	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.31e-05	0.000885	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.27e-05	0.000881	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.27e-05	0.00088	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.24e-05	0.000878	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.24e-05	0.000878	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	9.23e-05	0.000877	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.22e-05	0.000876	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.21e-05	0.000874	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.12e-05	0.000866	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.09e-05	0.000864	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.07e-05	0.000862	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.05e-05	0.000859	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	8.9e-05	0.000846	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.8e-05	0.000836	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.66e-05	0.000822	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.56e-05	0.000813	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.47e-05	0.000805	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.42e-05	0.0008	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.42e-05	0.0008	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.34e-05	0.000792	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.28e-05	0.000787	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.18e-05	0.000777	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.12e-05	0.000771	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.05e-05	0.000765	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.01e-05	0.000761	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.99e-05	0.000759	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.88e-05	0.000749	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.62e-05	0.000724	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.55e-05	0.000717	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.5e-05	0.000712	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.48e-05	0.000711	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.48e-05	0.000711	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.43e-05	0.000706	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.37e-05	0.0007	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.36e-05	0.000699	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.36e-05	0.000699	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.29e-05	0.000693	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.29e-05	0.000693	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.28e-05	0.000691	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.28e-05	0.000691	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	7.26e-05	0.00069	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.26e-05	0.000689	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.24e-05	0.000688	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.18e-05	0.000682	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.18e-05	0.000682	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.17e-05	0.000681	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.16e-05	0.00068	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.16e-05	0.00068	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.12e-05	0.000676	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.06e-05	0.00067	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.92e-05	0.000657	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.81e-05	0.000647	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.81e-05	0.000647	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.7e-05	0.000637	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.66e-05	0.000632	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.57e-05	0.000624	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.55e-05	0.000622	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.5e-05	0.000617	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.47e-05	0.000614	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.46e-05	0.000614	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.42e-05	0.00061	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.4e-05	0.000607	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.36e-05	0.000604	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.33e-05	0.000601	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.32e-05	0.0006	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.31e-05	0.000599	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.3e-05	0.000598	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.27e-05	0.000596	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.22e-05	0.000591	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.21e-05	0.000589	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.2e-05	0.000589	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.19e-05	0.000588	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.17e-05	0.000586	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.09e-05	0.000578	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	6.05e-05	0.000574	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.01e-05	0.00057	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	5.95e-05	0.000565	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.91e-05	0.000561	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.84e-05	0.000555	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.83e-05	0.000554	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.83e-05	0.000554	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.75e-05	0.000546	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.74e-05	0.000546	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.74e-05	0.000545	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.74e-05	0.000545	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.67e-05	0.000539	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.65e-05	0.000537	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.65e-05	0.000536	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.65e-05	0.000536	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.58e-05	0.00053	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.56e-05	0.000528	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.56e-05	0.000528	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.55e-05	0.000527	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.53e-05	0.000525	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.53e-05	0.000525	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.46e-05	0.000519	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.46e-05	0.000518	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.44e-05	0.000516	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.44e-05	0.000516	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.37e-05	0.00051	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.31e-05	0.000504	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.22e-05	0.000496	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.14e-05	0.000488	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.12e-05	0.000486	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.06e-05	0.000481	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.05e-05	0.00048	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.05e-05	0.00048	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.04e-05	0.000478	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.97e-05	0.000472	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.97e-05	0.000472	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.97e-05	0.000472	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.96e-05	0.000471	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.89e-05	0.000465	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.88e-05	0.000463	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.73e-05	0.000449	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.65e-05	0.000442	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.65e-05	0.000441	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.64e-05	0.000441	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.57e-05	0.000434	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.57e-05	0.000434	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.4e-05	0.000418	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.36e-05	0.000414	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.33e-05	0.000411	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.3e-05	0.000408	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.3e-05	0.000408	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.29e-05	0.000407	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.28e-05	0.000406	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.26e-05	0.000405	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.23e-05	0.000402	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.23e-05	0.000402	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.22e-05	0.0004	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.21e-05	0.0004	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.19e-05	0.000398	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.15e-05	0.000395	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.15e-05	0.000394	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.14e-05	0.000393	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.09e-05	0.000388	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.09e-05	0.000388	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.07e-05	0.000387	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.02e-05	0.000382	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.97e-05	0.000377	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.9e-05	0.000371	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.88e-05	0.000369	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.82e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.72e-05	0.000353	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.66e-05	0.000348	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.65e-05	0.000347	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.6e-05	0.000342	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	3.57e-05	0.000339	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	3.51e-05	0.000334	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.41e-05	0.000323	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.4e-05	0.000323	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.39e-05	0.000322	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.35e-05	0.000318	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.34e-05	0.000318	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.34e-05	0.000317	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.34e-05	0.000317	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.32e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.32e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.29e-05	0.000312	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.28e-05	0.000312	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.27e-05	0.000311	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.27e-05	0.000311	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.23e-05	0.000307	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.14e-05	0.000298	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.09e-05	0.000293	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.97e-05	0.000282	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.92e-05	0.000277	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.84e-05	0.00027	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.79e-05	0.000265	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.79e-05	0.000265	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.75e-05	0.000261	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.75e-05	0.000261	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.75e-05	0.000261	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.73e-05	0.00026	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.7e-05	0.000257	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.7e-05	0.000257	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.69e-05	0.000255	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.61e-05	0.000248	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.57e-05	0.000244	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.49e-05	0.000237	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.49e-05	0.000237	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.45e-05	0.000233	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.45e-05	0.000233	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.34e-05	0.000223	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.31e-05	0.000219	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.13e-05	0.000203	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.11e-05	0.000201	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.1e-05	0.0002	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.1e-05	0.000199	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.08e-05	0.000198	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.07e-05	0.000196	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2e-05	0.00019	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.98e-05	0.000188	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.97e-05	0.000187	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.95e-05	0.000185	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.94e-05	0.000184	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.91e-05	0.000181	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.84e-05	0.000175	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.81e-05	0.000172	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.79e-05	0.00017	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.77e-05	0.000168	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.65e-05	0.000156	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.62e-05	0.000154	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.61e-05	0.000153	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.59e-05	0.000151	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-05	0.000118	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.22e-05	0.000116	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.14e-05	0.000109	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.13e-05	0.000107	CbGpPWpGaD
